Inventor
HAMPRECHT DIETER
IT42 patents
⚠️ This page may combine multiple inventors who share the name “HAMPRECHT DIETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
9 patentsUS10640486B2May 5, 2020
Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
BOEHRINGER INGELHEIM INT4 citations71
US10399961B2Sep 3, 2019
Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
BOEHRINGER INGELHEIM INT4 citations71
US9920035B2Mar 20, 2018
Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
BOEHRINGER INGELHEIM INT0 citations52
US9308194B2Apr 12, 2016
Indanyloxyphenylcyclopropanecarboxylic acids
BOEHRINGER INGELHEIM INT1 citations51
US10221202B2Mar 5, 2019
Annelated phenoxyacetamides
BOEHRINGER INGELHEIM INT0 citations42
US10155749B2Dec 18, 2018
Substituted benzimidazolium compounds useful in the treatment of respiratory diseases
BOEHRINGER INGELHEIM INT0 citations42
US9938256B2Apr 10, 2018
Annelated benzamides
BOEHRINGER INGELHEIM INT0 citations42
US9328131B2May 3, 2016
Benzimidazolium compounds
BOEHRINGER INGELHEIM INT0 citations42
US8859559B2Oct 14, 2014
Substituted pyrazines and their use in the treatment of disease
BOEHRINGER INGELHEIM INT0 citations41
GLAXO GROUP LTD
8 patentsUS7855298B2Dec 21, 2010
Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine D3 receptors
GLAXO GROUP LTD11 citations82
US7799815B2Sep 21, 2010
Triazole derivatives as modulators of dopamine D3 receptors
GLAXO GROUP LTD7 citations72
US7803820B2Sep 28, 2010
3-triazolylthiaalkyl-3-azabicyclo (3-1-O) hexanes and their use as dopamine D3 receptor ligands
GLAXO GROUP LTD5 citations61
US7745458B2Jun 29, 2010
Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine D3 receptors
GLAXO GROUP LTD2 citations60
US7875643B2Jan 25, 2011
Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
GLAXO GROUP LTD6 citations57
US8003638B2Aug 23, 2011
7-pyrazolylbenzazepines having affinity for D3 receptor
GLAXO GROUP LTD0 citations51
US7807698B2Oct 5, 2010
Azabicyclo[3.1.0]hexane derivatives as modulators of the dopamine D3 receptor
GLAXO GROUP LTD1 citations51
US7776904B2Aug 17, 2010
Azabicyclo [3.1.0] hexylphenyl derivatives as modulators of dopamine D3 receptors
GLAXO GROUP LTD0 citations50
AUTIFONY THERAPEUTICS LTD
7 patentsUS9849131B2Dec 26, 2017
Imidazolidinedione derivatives
AUTIFONY THERAPEUTICS LTD4 citations83
US9216967B2Dec 22, 2015
Imidazolidinedione derivatives
AUTIFONY THERAPEUTICS LTD5 citations83
US9422252B2Aug 23, 2016
Triazoles as Kv3 inhibitors
AUTIFONY THERAPEUTICS LTD5 citations82
US10058551B2Aug 28, 2018
Imidazolidinedione derivatives
AUTIFONY THERAPEUTICS LTD3 citations72
US11180461B2Nov 23, 2021
Triazoles as Kv3 inhibitors
AUTIFONY THERAPEUTICS LTD0 citations61
US10611735B2Apr 7, 2020
Triazoles as Kv3 inhibitors
AUTIFONY THERAPEUTICS LTD0 citations50
US10160730B2Dec 25, 2018
Triazoles as KV3 inhibitors
AUTIFONY THERAPEUTICS LTD0 citations50
HAMPRECHT DIETER
3 patentsUS8841309B2Sep 23, 2014
Substituted pyrazines and their use in the treatment of disease
HAMPRECHT DIETER15 citations82
US8633182B2Jan 21, 2014
Indanyloxyphenylcyclopropanecarboxylic acids
HAMPRECHT DIETER11 citations82
US9078909B2Jul 14, 2015
Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof
HAMPRECHT DIETER0 citations40